Loeys B, Van Maldergem L, Mortier G, et al. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 2002;11: 2113-2118.
Markova D, Zou Y, Ringpfeil F, et al. Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 2003;72: 998-1004.
Elahi E, Kalhor R, Banihosseini SS, et al. Homozygous missense mutation in fibulin 5 in an Iranian autosomal recessive pedigree and associated haplotype. J Invest Dermatol 2006;126:1506-1509.
Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 2006;78:1075-1080.
Tassabehji M, Metcalfe K, Hurst J, et al. An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa. Hum Mol Genet 1998;7:1021-1028.
Zhang M-C, He L, Giro M, Yong SL, Tiller GE, Davidson JM. Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J Biol Chem 1999;274: 981-986.
Rodriguez-Revenga L, Iranzo P, Badenas P, Puig S, Carrio A, Mila M. A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. Arch Dermatol 2004;140:1135-1139.
Urban Z, Gao J, Pope FM, Davis EC. Autosomal dominant cutis laxa with severe lung disease: synthesis and matrix deposition of mutant tropoelastin. J Invest Dermatol 2005;124:1193-1199.
Szabo Z, Crepeau MW, Mitchell AL, et al. Aortic aneuris-mal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 2006;43:255-258.
Morava E, Wopereis S, Coucke P, et al. Defective protein glycosylation in patients with cutis laxa syndrome. Eur J Hum Genet 2005;13:414-421.
Biver A, De Rijcke S, Toppet V, Ledoux-Corbusier M, Van Maldergem L. Congenital cutis laxa with ligamentous laxity and delayed development, Dandy-Walker malformation and minor heart and osseous defects. Clin Genet 1994;45:318-322.
Jaeken J, Van Eijk HG, van der Heul C, Corbeel L, Eeck-els R, Eggermont E. Sialic acid-deficient serum and cere-brospinal fluid transferring in a newly recognized genetic syndrome. Clin Chim Acta 1984;144:244-247.
Carchon HA, Chevigne R, Falmagne JB, Jaeken J. Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis. Clin Chem 2004;50:101-111.
Wopereis S, Grünewald S, Morava E, et al. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem 2003;49:1839-1845.
Litzman J, Buckova H, Ventruba J, Holcikova A, Mikyska P, Lokaj J. A concurrent occurrence of cutis laxa, Dandy-Walker syndrome and immunodeficiency in a girl. Acta Paediatr 2003;92:861-864.
Hansske B, Thiel C, Lubke T, et al. Deficiency of UDP-galactose: N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 2002;109:725-733.
Peters V, Penzien JM, Reiter G, et al. Congenital disorder of glycosylation IId (CDG-IId) - a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 2002;33:27-32.
Williams RS, Swisher CN, Jennings M, Ambler M, Caviness VS Jr. Cerebro-ocular dysgenesis(Walker-Warburg syndrome): neuropathologic and etiologic study. Neurology 1984;34:1531-1541.
Dobyns WB, Kirkpatrick JB, Hittner HM, Roberts RM, Kretzer FL. Syndromes with lissencephaly II: Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am J Med Genet 1985;22:157-195.
Haltia M, Leivo I, Somer H, et al. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 1997; 41:73-80.
Miller G, Ladda RL, Towfighi J. Cerebro-ocular dysplasia-muscular dystrophy (Walker-Warburg) syndrome: findings in a 20-week-old fetus. Acta Neuropathol 1991;82: 234-238.
Takada K, Nakamura H, Suzumori K, Ishikawa T, Sugiyama N. Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD): a case analysis. Acta Neuropathol 1987;74:300-306.
Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394:388-389.
Beltran-Valero de Bernabe D, Voit T, Longman C, et al. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet 2004;41:e61.
Longman C, Brockington M, Torelli S, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 2003;12:2853-2861.
Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001;1: 717-724.
Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2003;71:1033-1043.
van Reeuwijk J, Janssen M, van den Elzen C, et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005;42:907-912.
Chiba A, Matsumura K, Yamada H, et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan: the role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 1997; 272:2156-2162.
Henry MD, Satz JS, Brakebusch C, et al. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization. J Cell Sci 2001;114:1137-1144.
Olson EC, Walsh CA. Smooth, rough and upside-down neocortical development. Curr Opin Genet Dev 2002;12: 320-327.
Piao X, Hill RS, Bodell A, et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004;303:2033-2036.
Chang BS, Piao X, Bodell A, et al. Bilateral frontal polymi-crogyria: clinical and radiological features in ten families with linkage to chromosome 16. Ann Neurol 2003;56: 596-606.
Piao X, Chang BS, Bodell A, et al. Genotype-phenotype analysis of human frontoparietal polymicrogyria syndromes. Ann Neurol 2005;58:680-687.
Dobyns WB, Patton MA, Stratton RF, MastrobattistaJM, Blanton SH, Northup H. Cobblestone lissencephaly with normal eye and muscle. Neuropediatrics 1996;27:70-75.
Straussberg R, Gross S, Amir J, Gadoth N. A new autosomal recessive syndrome of pachygyria. Clin Genet 1996; 50:498-501.
Piao X, Basel-Vanagaite L, Straussberg R, et al. An autosomal recessive form of bilateral frontoparietal polymicrogyria maps to chromosome 16q12.2-q21. Am J Hum Genet 2002;70:1028-1033.
Jin Z,Tietjen I, Bu L, et al. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 2007;16:1972-1985.
Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M, et al. A mutation in SNAP29, a SNARE protein involved in intracellular trafficking causes a new neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 2005;77:242-251.
Kornak U, Reynders E, Dimopoulou A, et al., ARCL De-bré Study Group. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H + -ATPase subunit ATP6V0A2. Nat Genet 2008;40:32-34.
